Revanth Dodla

Revanth Dodla has a diverse background in corporate strategy, investment, and financial analysis. Currently serving in a Corporate Strategy role at Indegene since August 2021, Revanth has previously worked as an Investment Professional at Endiya Partners focusing on early-stage investments in healthcare and technology from 2017 to 2019. Prior to that, experience as an Equity Analyst at J.P. Morgan involved US biotech sell-side equity research from 2014 to 2017. Revanth also contributed as an Analyst at Verity Knowledge Solutions Pvt. Ltd. in 2013-2014, supporting global UBS healthcare investment banking teams in M&A, public offerings, and private placements. Educational qualifications include an MBA from the Indian School of Business and a B.Tech from the Indian Institute of Technology, Madras.